Business
Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform
LONDON, February 10, 2026--Calla Lily Clinical Care, a women’s health-focused medical technology company, and Merck, a leading science and technology company, have entered a strategic collaboration to support the continued development of Callavid®, a novel platform for intravaginal drug delivery. The collaboration represents the first industry partnership for the Callavid technology.
About this update from Merck & Company, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":244,"url":"https://media.zenfs.com/en/business-wire.com/06f61e32b43f4615d8e9fd1370d9a27b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UmKO1AdSSZq.h74hKmmYoQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIyOTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/06f61e32b43f4615d8e9fd1370d9a27b","width":960,"height":229},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/AgnSAtOW52Ix1dWHNhB_SQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD00ODg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/06f61e32b43f4615d8e9fd1370d9a27b","width":1024,"height":244}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Enhancing patient treatment experience and care with a new self-administered solution for vaginal therapeutics","length":110,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Versatile platform technology developed from a safe, award-winning, FDA-cleared medical device","length":94,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Strategic collaboration supporting the continued development of a novel intravaginal drug delivery approach to address unmet needs in women’s health","length":148,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":352,"olType":false},{"type":"text","content":"LONDON, February 10, 2026--(BUSINESS WIRE)--Calla Lily Clinical Care, a women’s health-focused medical technology company, and Merck, a leading science and technology company, have entered a strategic collaboration to support the continued development of Callavid®, a novel platform for intravaginal drug delivery. The collaboration represents the first industry partnership for the Callavid technology.","length":403,"tagName":"p"},{"type":"text","content":"Callavid is a transformational leak-resistant medical device designed to address challenges associated with the self-administration of vaginal therapeutics. Administration via the vaginal route can be associated with increased patient anxiety related to positioning, dosing accuracy, and concerns around leakage, particularly for certain therapeutics used in fertility treatments, oncology, and hormone therapies.","length":413,"tagName":"p"},{"type":"text","content":"Developed by the team...